Artificial Intelligence

Artificial intelligence and machine learning are increasingly transforming the healthcare sector. From spotting malignant tumours to reading CT scans and mammograms, AI/ML-based technology is faster and more accurate than traditional devices - or even the best doctors. But along with the benefits come new risks and regulatory challenges.

Technology will play a part in managing responsible camping in New Zealand this summer, the government has announced.\r\n\r\n

Imagine if a computer could learn from molecules found in nature and use an algorithm to generate new ones. Then imagine those molecules could get printed and tested in a lab against some of the nastiest, most dangerous bacteria out there—bacteria quickly becoming resistant to our current antibiotic options.

Pirelli is the first tyre company in the world to transmit information detected by intelligent tyres regarding the road surface via the 5G network.

Aeon will launch a new online business with OSP, harnessing Ocado's unique, proprietary customer fulfilment centres and end-to-end software applications to serve millions of customers across Japan.\r\n\r\n

Designing the best molecular building blocks for battery components is like trying to create a recipe for a new kind of cake, when you have billions of potential ingredients. The challenge involves determining which ingredients work best together — or, more simply, produce an edible (or, in the case of batteries, a safe) product.

A smart knee bandage supports arthrosis patients in determining the right amount of daily exercise. All relevant data on the strains of the joints are collected and transferred to the patient's mobile phone.

Autonomous driving technologies are disrupting the business models for the traditional auto industry. Latest research from IDTechEx forecasts that autonomous driving technologies will accelerate the arrival of peak car sales, in 2031.

Placentas can provide critical information about the health of the mother and baby, but only 20 percent of placentas are assessed by pathology exams after delivery in the U.S. The cost, time and expertise required to analyze them are prohibitive.